Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001622627-26-000002·Cellectar Biosciences, Inc.
Schedule 13G ownership disclosure
CELLECTAR BIOSCIENCES INC
Common Shares · CUSIP: 15117F500
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Rosalind Advisors, Inc.
Shares: 247,715.00 · Class: 5.5%
- SALAMON STEVEN A J
Shares: 247,715.00 · Class: 5.5%
- Aharon Gil
Shares: 247,715.00 · Class: 5.5%
- Rosalind Master Fund L.P.
Shares: 185,036.00 · Class: 4.1%
- Rosalind Opportunities Fund I L.P.
Shares: 62,678.00 · Class: 1.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001622627-26-000002
- Form type
- SCHEDULE 13G/A
- Filer
- Cellectar Biosciences, Inc.
- CIK
- CIK 1279704
- Filed
- Feb 10, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership